phase readout
saveNCT03169881: Darbepoetin Trial to Improve Red Cell Mass and Neuroprotection in Preterm Infants
COMPLETEDupdated 28m ago
community read0 votes
Sponsor: NICHD Neonatal Research Network. Phase: PHASE3. Conditions: Neurocognitive, Neuroprotective, Neonatal, Neurodevelopmental Impairment
view source ↗
comments(0)
5-min edit window · permanent after that